Compagnie Lombard Odier SCmA’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $172K | Hold |
9,000
| – | – | ﹤0.01% | 262 |
|
|
2025
Q4 | $218K | Hold |
9,000
| – | – | ﹤0.01% | 245 |
|
|
2025
Q3 | $230K | Hold |
9,000
| – | – | ﹤0.01% | 243 |
|
|
2025
Q2 | $194K | Hold |
9,000
| – | – | ﹤0.01% | 239 |
|
|
2025
Q1 | $206K | Hold |
9,000
| – | – | ﹤0.01% | 256 |
|
|
2024
Q4 | $234K | Hold |
9,000
| – | – | ﹤0.01% | 230 |
|
|
2024
Q3 | $225K | Hold |
9,000
| – | – | ﹤0.01% | 234 |
|
|
2024
Q2 | $193K | Hold |
9,000
| – | – | ﹤0.01% | 247 |
|
|
2024
Q1 | $167K | Hold |
9,000
| – | – | ﹤0.01% | 277 |
|
|
2023
Q4 | $146K | Hold |
9,000
| – | – | ﹤0.01% | 319 |
|
|
2023
Q3 | $124K | Hold |
9,000
| – | – | ﹤0.01% | 331 |
|
|
2023
Q2 | $199K | Hold |
9,000
| – | – | 0.01% | 265 |
|
|
2023
Q1 | $196K | Hold |
9,000
| – | – | ﹤0.01% | 293 |
|
|
2022
Q4 | $164K | Hold |
9,000
| – | – | ﹤0.01% | 317 |
|
|
2022
Q3 | $205K | Hold |
9,000
| – | – | 0.01% | 296 |
|
|
2022
Q2 | $124K | Hold |
9,000
| – | – | ﹤0.01% | 358 |
|
|
2022
Q1 | $205K | Hold |
9,000
| – | – | ﹤0.01% | 306 |
|
|
2021
Q4 | $335K | Hold |
9,000
| – | – | 0.01% | 291 |
|
|
2021
Q3 | $381K | Hold |
9,000
| – | – | 0.01% | 276 |
|
|
2021
Q2 | $401K | Hold |
9,000
| – | – | 0.01% | 258 |
|
|
2021
Q1 | $324K | Hold |
9,000
| – | – | 0.01% | 333 |
|
|
2020
Q4 | $359K | Hold |
9,000
| – | – | 0.01% | 264 |
|
|
2020
Q3 | $260K | Hold |
9,000
| – | – | 0.01% | 253 |
|
|
2020
Q2 | $147K | Hold |
9,000
| – | – | ﹤0.01% | 297 |
|
|
2020
Q1 | $85K | Buy |
+9,000
| New | +$124K | ﹤0.01% | 311 |
|
Other funds holding BLFS
CC
VCM
FAM